The GARDian program provides consistency of therapy. Not all IVIG’s are the same, each varies in process and formulation. These differences can be important considerations when choosing an appropriate IVIG therapy. Enrolling your patients in the GARDian program helps provide continued access to patients who rely on GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] when patients experience life events such as a change in physician, site of care, or residence. Using a simple, voluntary enrollment process administered through patients’ healthcare providers, enrollees will have the comfort of knowing that GAMMAGARD therapies will be available to them today and tomorrow.
Visit www.MyGARDian.com for more information about this program.
Please see Important Risk Information
Please see full Prescribing Information
Please see Important Risk Information
Please see full Prescribing Information
The Aralast NP AATmosphere program surrounds patients with Alpha-1 support and also benefits medical practices by helping to minimize the amount of time they need to manage patients.
AATmosphere provides support from therapy initiation and care coordination to handling the day-to-day concerns and insurance issues of AATD patients and their families. Enrolling patients in the Aralast NP AATmosphere program puts AATD patients in touch with a team of healthcare and benefits specialists, one-on-one AATmosphere support from Alpha-1 patients, insurance assistance, and current information. AATmosphere is sponsored by Aralast NP augmentation therapy and is easily accessed over the phone or online.
If you would like to contact Aralast NP AATmosphere call 1-866-ARALAST or visit http://www.aatmosphere.com/knowledge_network/index.html to enroll today.
Download an Enrollment Form for your patients at: http://www.aatmosphere.com/knowledge_network/index.html.
Please see Important Risk Information
Please see full Prescribing Information
WinRho® SDF Liquid offers a comprehensive collection of support programs for patients and physicians involved in the treatment of ITP. These include patient education and several online resources to help support patients, families, and physicians in increasing their disease knowledge and the treatment of ITP.
In addition, we offer comprehensive reimbursement programs to help guide and support patients, families and physicians with the treatment of WinRho®. These include Baxter’s BioScience Department of Healthcare Economics, which offers support and advocacy to healthcare providers and their families that rely on our therapies. The Billing for Healthcare Professionals offers specific guidance on billing codes and medical necessity verification and reimbursement. A reimbursement hotline at 1-800-4WINRHO also assists patients, families and physicians coverage reimbursement and coding. Other links online include reimbursement information for Medicare and Medicaid, as well as the Children’s Health Insurance Program. Learn more about ITP education and Baxter’s reimbursement programs at: www.winrho.com.
Please see Important Risk Information
Please see full Prescribing Information
The hotline will help identify potential billing codes required on claims.
The hotline will monitor public and private payer coverage policies to ensure you have the most up-to-date coverage information and answer questions about insurance coverage and reimbursement for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% and GAMMAGARD S/D [Immune Globulin Intravenous (Human)], as well as other reimbursement questions.
A sterile, nonpyrogenic preparation of albumin in a single-dosage
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
